Covance, Pathoquest Collaborate on NGS Safety Platform

November 7, 2013 | Covance and Pathoquest have signed an agreement to build an NGS-based biosafety assessment platform. The platform would detect contaminants within monoclonal antibodies or vaccines. Outsourcing Pharma


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.